References
- WHO: Obesity and overweight. World Health Organization; 2021 Jun 9 [cited 2023 Mar 24]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
- de Piano A, Tock L, Carnier J, et al. Negative correlation between neuropeptide Y/agouti-related protein concentration and adiponectinemia in nonalcoholic fatty liver disease obese adolescents submitted to a long-term interdisciplinary therapy. Metabolism. 2010 May;59(5):613–619.
- Dâmaso AR, de Piano A, Campos RM, et al. Multidisciplinary approach to the treatment of obese adolescents: effects on cardiovascular risk factors, inflammatory profile, and neuroendocrine regulation of energy balance. Int J Endocrinol. 2013;2013:541032. doi: 10.1155/2013/541032
- Katzmarzyk PT, Barreira TV, Broyles ST, et al. Relationship between lifestyle behaviors and obesity in children ages 9-11: results from a 12-country study. Obesity (Silver Spring). 2015 Aug;23(8):1696–1702.
- Corgosinho FC, Almeida SS, Tock L, et al. LEPR polymorphism may affect energy balance during weight loss among Brazilians obese adolescents. Neuropeptides. 2017 Dec;66:18–24.
- Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017 Jan 3;127(1):1–4. doi: 10.1172/JCI92035
- Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018 Feb 26;20(2):12. doi: 10.1007/s11906-018-0812-z
- Graf C, Ferrari N. Metabolic syndrome in children and adolescents. Visc Med. 2016;32(5):357–362. doi: 10.1159/000449268
- Leão da Silva P, de Mello MT, Cheik NC, et al. Reduction in the leptin concentration as a predictor of improvement in lung function in obese adolescents. Obes Facts. 2012;5(6):806–820. doi: 10.1159/000345840
- Sanches PL, de Mello MT, Elias N, et al. Hyperleptinemia: implications on the inflammatory state and vascular protection in obese adolescents submitted to an interdisciplinary therapy. Inflammation. 2014 Feb;37(1):35–43.
- Carvalho-Ferreira JP, Masquio DC, da Silveira Campos RM, et al. Is there a role for leptin in the reduction of depression symptoms during weight loss therapy in obese adolescent girls and boys? Peptides. 2015 Mar;65:20–28.
- Kravchychyn ACP, Campos RMDS, Corgosinho FC, et al. The long-term impact of high levels of alpha-melanocyte-stimulating hormone in energy balance among obese adolescents. Ann Nutr Metab. 2018;72(4):279–286. doi: 10.1159/000488005
- Dâmaso AR, de Piano A, Sanches PL, et al. Hyperleptinemia in obese adolescents deregulates neuropeptides during weight loss. Peptides. 2011 Jul;32(7):1384–1391.
- Masquio DC, de Piano A, Campos RM, et al. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents. Br J Nutr. 2015 Jun 28;113(12):1920–1930. doi: 10.1017/S0007114515001129
- Ferreira YAM, Kravchychyn ACP, Vicente SECF, et al. Influence of magnitude of weight loss on Adipo/lep ratio in adolescents with obesity undergoing multicomponent therapy. Cytokine. 2020 Jul;131:155111.
- Roche J, Corgosinho FC, Isacco L, et al. A multidisciplinary weight loss intervention in obese adolescents with and without sleep-disordered breathing improves cardiometabolic health, whether SDB was normalized or not. Sleep Med. 2020 Nov;75:225–235.
- Gallè F, Valerio G, Daniele O, et al. Multidisciplinary treatment for childhood obesity: a two-year experience in the Province of Naples, Italy. Children (Basel). 2022 Jun 4;9(6):834. doi: 10.3390/children9060834